Discover 707 paid clinical trials in Olathe, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 707
Doppler Ultrasound Imaging of Plastic Surgery Patients for DVT Detection
for
Deep Venous Thrombosis
Location: Leawood KS
Sponsor: Swanson Center
Sex: All
Age: 18+
Code: NCT02123550
Recruiting
Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM
for
Epiretinal Membrane
Location: Overland Park KS, Prairie Village KS, Columbia MO,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 50+
Code: NCT05145491
Recruiting
Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
for
Proliferative Diabetic Retinopathy (PDR)
Location: Overland KS, West Des Moines IA, St Louis MO, Edmond OK,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 18+
Code: NCT06790784
Phase3, Recruiting
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
for
Non-muscle Invasive Bladder Cancer
Location: Overland Park KS, Fairway KS, Westwood KS,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07206225
Phase1, Recruiting
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
for
Acute Myeloid Leukemia,
Location: Overland Park KS, Fairway KS, Westwood KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT05886049
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Female Athletes
for
Atrophy
Location: Overland Park KS
Sponsor: University of Kansas Medical Center
Sex: Female
Age: 18 - 45
Code: NCT05869812
Phase2, Recruiting
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
for
Accelerated Phase Myeloproliferative Neoplasm,
Location: Overland Park KS, Fairway KS, Westwood KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06661915
Phase2, Recruiting
Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
for
Burkitt Lymphoma, Double-Expressor Lymphoma,
Location: Overland Park KS, Fairway KS, Westwood KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07069699
Phase1, Phase2, Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
for
Core Binding Factor Acute Myeloid Leukemia
Location: Overland Park KS, Fairway KS, Westwood KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT06917911
Phase2, Recruiting
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
for
Cutaneous Melanoma, Stage II
Location: Overland Park KS, Westwood KS, Kansas City MO,
Sponsor: Melanoma and Skin Cancer Trials Limited
Sex: All
Age: 18+
Code: NCT03860883
Recruiting
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia,
Location: Overland Park KS, Fairway KS, Westwood KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554406
Phase2, Recruiting
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy
for
Malignant Solid Neoplasm
Location: Overland Park KS, Westwood KS, Kansas City KS,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05642611
Phase3, Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Overland Park KS, Fairway KS, Westwood KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase2, Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Overland Park KS, Fairway KS, Westwood KS,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
for
Carcinoma, Non-Small Cell Lung,
Location: Overland Park KS, Fairway KS, Kansas City KS,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT04389632
Phase1, Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Overland Park KS, Fairway KS, Westwood KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06317649
Phase2, Recruiting
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
for
Metastatic Colorectal Adenocarcinoma,
Location: Overland Park KS, Fairway KS, Westwood KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06696768
Phase1, Recruiting
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
for
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
Location: Overland Park KS, Fairway KS, Westwood KS,
Sponsor: NRG Oncology
Sex: All
Age: 45 - 70
Code: NCT05080673
Recruiting
New
Evaluate the Effect of Vimseltinib on P-glycoprotein (P-gp) Inhibition in Healthy Male Participants
for
Healthy Male Participants
Location: Overland Park KS
Sponsor: Deciphera Pharmaceuticals, LLC
Sex: Male
Age: 18 - 55
Code: NCT07744802
Phase1, Recruiting
New
Abuse Potential of Gabapentin Taken Orally Concomitantly With Oxycodone Hydrochloride in Healthy, Non-Drug-Dependent, Recreational Opioid Users